Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)

Forecast Expected deadline October 15, 2026 Opportunity PAR-27-049

National Institutes of Health plans to offer grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It is a forecast: the notice is expected around August 17, 2026, with applications due around October 15, 2026.

From the official notice on Grants.gov, last changed May 14, 2026. Checked October 31, 2026.

Key dates

Forecast postedJune 12, 2025
Expected postingAugust 17, 2026
Expected deadlineOctober 15, 2026
Expected award dateDecember 4, 2026

Add the deadline to your calendar

Who can apply

This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Category: Health.

How to apply

  1. Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
  2. Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
  3. Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.

Questions go to National Institute of Arthritis and Musculoskeletal and Skin Diseases, AncillaryStudies@nih.gov, Please contact via e-mail..

Open the official notice

Questions people ask

Who can apply for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?

National Institutes of Health accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?

Expected deadline October 15, 2026. Confirm the date and time in the official notice on Grants.gov.

Similar open grants